TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Dr Reddy’s Laboratories ( (RDY) ) has provided an announcement.
On December 9, 2025, Dr. Reddy’s Laboratories announced the allotment of 9,165 equity shares to eligible employees under its Employee Stock Options Schemes of 2002 and 2007. This move is part of the company’s ongoing efforts to reward and retain its workforce, potentially enhancing employee satisfaction and motivation. The issuance of these shares, which are fully paid up and rank pari passu with existing shares, reflects the company’s commitment to its employee benefits programs and could positively impact its operational dynamics and stakeholder relations.
The most recent analyst rating on (RDY) stock is a Buy with a $15.50 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.
Spark’s Take on RDY Stock
According to Spark, TipRanks’ AI Analyst, RDY is a Outperform.
Dr Reddy’s Laboratories has a strong financial foundation and strategic growth initiatives, but faces challenges in the U.S. generics market and regulatory issues. The technical indicators suggest a bearish trend, and the valuation is reasonable but not compelling. The mixed sentiment from the earnings call reflects both opportunities and risks.
To see Spark’s full report on RDY stock, click here.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories Limited is a pharmaceutical company based in Hyderabad, India. It is involved in the manufacturing and marketing of a wide range of pharmaceutical products and services, with a focus on generic medications and active pharmaceutical ingredients. The company is listed on major stock exchanges including the National Stock Exchange of India, BSE Ltd., and the New York Stock Exchange.
Average Trading Volume: 1,060,172
Technical Sentiment Signal: Hold
Current Market Cap: $11.76B
Find detailed analytics on RDY stock on TipRanks’ Stock Analysis page.